Amyloidosis Support Groups Inc
EIN: 20-2909816Wood Dale, ILZIP: 60191
H90 - Medical Research501(c)(3)
Mission
To form Amyloidosis Support Groups were needed, to have all Amyloidosis support Groups be self sustaining through donations, to fund and maintain libraries of education materials for all support groups, to fund group projects that wil help in spreading awareness and fundraising and to help finance the annual education retreat for training new and current group leaders and facilitators.
Financials
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2023 | $430k | $0 | $885k |
Compensation
Similar Organizations
SAEM RESEARCH FOUNDATION
$515k revenueDes Plaines, IL
Same sector (H90)Similar revenue ($515k vs $430k)Same state (Illinois)
STAAR OVARIAN CANCER
$400k revenueChicago, IL
Similar sector (H)Very similar revenue ($400k vs $430k)Same state (Illinois)
The North American Hair Research Society
$401k revenueChicago, IL
Similar sector (H)Very similar revenue ($401k vs $430k)Same state (Illinois)
OMEGA MEDICAL GRANTS ASSOCIATION
$433k revenueRosemont, IL
Similar sector (H)Very similar revenue ($433k vs $430k)Same state (Illinois)
CARDIAC SURGERY CLINICAL RESEARCH CENTER
$394k revenueOakbrook Terrace, IL
Similar sector (H)Very similar revenue ($394k vs $430k)Same state (Illinois)
SOCIETY FOR EAR NOSE AND THROAT ADVANCES
$400k revenueWarrenville, IL
Similar sector (H)Very similar revenue ($400k vs $430k)Same state (Illinois)
NEUROFIBROMATOSIS NETWORK
$410k revenueWheaton, IL
Similar sector (H)Very similar revenue ($410k vs $430k)Same state (Illinois)
Sleep Research Society Foundation (SRSF)
$452k revenueDarien, IL
Similar sector (H)Very similar revenue ($452k vs $430k)Same state (Illinois)
FOUNDATION FOR PHYSICAL MEDICINE
$431k revenueRosemont, IL
Similar sector (H)Very similar revenue ($431k vs $430k)Same state (Illinois)
Team Bright Side Inc
$369k revenueNorthfield, IL
Similar sector (H)Similar revenue ($369k vs $430k)Same state (Illinois)Similar size (6 vs 6 executives)
Data from IRS Form 990 filings (2023).